Cardioblate ablation systems (Medtronic Inc.) for atrial fibrillation

Record ID 32011000833
English
Authors' objectives:

Atrial fibrillation (AF) is the most commonly diagnosed cardiac rhythm disturbance and it is characterized by rapid, uncoordinated contractions of the upper chambers of the heart. Although AF occurs in a high percentage of patients who have mitral valve disease, it can also occur in individuals who have no associated cardiac abnormalities. During AF, atrial blood flow can become relatively stagnant, allowing clots to form that can cause strokes. In addition, the atrial arrhythmia can spread to the lower chambers of the heart, causing dangerous ventricular arrhythmias that may result in loss of blood pressure, fainting, heart attack, or death. AF is usually classified as paroxysmal, chronic, permanent, or persistent. Paroxysmal AF occurs intermittently and varies in frequency and duration from a few seconds to several hours or even days. In contrast, chronic AF is persistent and usually fails to respond to drug therapy or other nonpharmacologic treatments.

Details
Project Status: Completed
Year Published: 2010
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Atrial Fibrillation
  • Catheter Ablation
  • Technology Assessment, Biomedical
Contact
Organisation Name: HAYES, Inc.
Contact Address: 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name: saleinfo@hayesinc.com
Contact Email: saleinfo@hayesinc.com
Copyright: 2010 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.